Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Chongya Zhai"'
Autor:
Xuanhong Jin, Yang Pan, Cheng Cheng, Hangchen Shen, Chongya Zhai, Kailai Yin, Xinyu Zhu, Hongming Pan, Liangkun You
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundIn individuals receiving treatment with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), those exhibiting positive PD-L1 expression might experience reduced progression-free survival (PFS). However, the effects on ov
Externí odkaz:
https://doaj.org/article/235695dd643744f7a64d24fb683cb78d
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract In the 8th edition of the American Joint Committee on Cancer (AJCC) staging system for Non-Small Cell Lung Cancer (NSCLC), tumors exhibiting main bronchial infiltration (MBI) near the carina and those presenting with complete lung obstructiv
Externí odkaz:
https://doaj.org/article/8dfe5d72a35e40e0b6e311f7809fe478
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Cancer survivors are vulnerable to frailty. While few studies have focused on the association of frailty with mortality risk among cancer survivors, the current study aimed to reveal this association. In this cohort study, 4723 cancer surviv
Externí odkaz:
https://doaj.org/article/76a1f72a839144dea335b2e85ec288d8
Autor:
Chongya Zhai, Xuanhong Jin, Liangkun You, Na Yan, Jie Dong, Sai Qiao, Yuhong Zhong, Yu Zheng, Hongming Pan
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-19 (2024)
Abstract Background Programmed cell death protein 1 (PD-1) checkpoint inhibitors such as pembrolizumab are novel therapeutics used to treat various advanced malignancies. Immune-related adverse events are common, among the most serious of these toxic
Externí odkaz:
https://doaj.org/article/e1ae3115a2674a4287c70240699c1b97
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundBoth anlotinib and programmed death 1 (PD-1) monoclonal antibody (mAb) have been approved for the third line treatment of metastatic non-small cell lung cancer (NSCLC). However, the combination of these two standard therapies has not been i
Externí odkaz:
https://doaj.org/article/a93d20acd4274e49b465ba83cd02918c
Autor:
Haizhou Lou, Chongya Zhai, Liu Gong, Hong Pan, Hongming Pan, Yihong Zhang, Mei Yang, Zimin Hu
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Recent advances in genomic medicine have identified novel gene mutations that contribute to an increased risk of CRC. Here, we describe a diagnosis of colon cancer in a 63-year-old
Externí odkaz:
https://doaj.org/article/799fe45da1514aafb87df8c992353d69
Background Cancer patients are vulnerable to frailty. While few studies have focused on its association with the mortality risk among cancer patients, the current study aims to reveal this association. Methods In this cohort study, 4723 cancer patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96799c06c4ba014fd07419b4aa797f43
https://doi.org/10.21203/rs.3.rs-2608451/v1
https://doi.org/10.21203/rs.3.rs-2608451/v1
Autor:
Xinmei Yang, Si Lu, Jiawei Shou, Hao Liu, Wei Zhang, Junjie Ni, Liangkun You, Shengpeng Shao, Chongya Zhai, Sujing Jiang, Rongjie Zhao, Hongming Pan, Weidong Han
Publikováno v:
Aging (Albany NY)
We investigated the role of the competing endogenous RNA (ceRNA) network in the development and progression of pancreatic adenocarcinoma (PAAD). We analyzed the expression profiles of PAAD and normal pancreatic tissues from multiple GEO databases and
Autor:
Xiao-Xi Xie, Meng-Ting Tong, Hao Liu, Xiaoyun Zhou, Jing Wang, Xinbing Sui, Da Li, Hong Hu, Yan-Hua Zhang, Hongming Pan, Jiansheng Xie, Chongya Zhai
Publikováno v:
Combinatorial Chemistry & High Throughput Screening. 21:801-805
Background: Esophageal cancer (EC) is a common digestive system tumor, characterized by high invasion, apparent lethality, and poor prognosis. Direct diffusion is the major metastatic mechanism of early EC, whereas advanced EC is spread mainly by lym
Autor:
Hong Pan, Yihong Zhang, Zimin Hu, Haizhou Lou, Mei Yang, Chongya Zhai, Hongming Pan, Liu Gong
Publikováno v:
The Journal of International Medical Research
Colorectal cancer (CRC) is a leading cause of cancer death worldwide. Recent advances in genomic medicine have identified novel gene mutations that contribute to an increased risk of CRC. Here, we describe a diagnosis of colon cancer in a 63-year-old